Nebenwirkungen · Myalepta
Myalepta 3 mg powder for solution for injection. Myalepta 5.8 mg powder for solution for injection. Myalepta 11.3 mg powder for solution for injection. · Abschnitt 4.8 · PDF-Seite 10
HOS-136647 · Präparat HOS-097896
Adverse reactions are classified by MedDRA System Organ Class and absolute frequency in Table 7. Frequencies are defined as very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from available data). Due to the number of patients with generalised and partial LD treated in clinical trials, it is not possible to detect with certainty, events which occur at a frequency of < 1%.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-06T16:51:00Z · SHA-256 8dc700b61702039d2472e9b5c7cadc8ee82ba9cfc98f829db4381f0e7da4f8ef · Passage dc95b66e484b9ef4406726806b627ed9b63600e6ae2a822ec7c11c816d141401 · Zeichen 698–1191 im Abschnitt